Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2018 Congress

Will CAR T cell therapy replace allogenic transplantation in lymphoma?

Will CAR T cell therapy replace allogenic transplantation in lymphoma? - 2nd vote and conclusions

Date

20 Oct 2018

Session

Will CAR T cell therapy replace allogenic transplantation in lymphoma?

Topics

Immunotherapy

Tumour Site

Lymphomas

Presenters

Martin Dreyling

Authors

M.H. Dreyling

Author affiliations

  • Medicine Iii, Ludwig Maximilians University - Grosshadern, 81377 - Munich/DE
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.